Drawing for NEXUS GLOBAL GROUP

USPTO serial 99638532

NEXUS GLOBAL GROUP

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MCMILLAN, CHRISTOPHER J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with NEXUS GLOBAL GROUP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew J. Gryzlo

Matthew J. Gryzlo Barnes & Thornburg LLPOne North Wacker Drive, Suite 4400Chicago, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
035New product commercialization services; Competitive intelligence services; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Business consultation and management regarding marketing activities and launching of new products; Brand positioning services; Business strategy development services; Marketing and branding services, namely, providing customized communication programs to obtain consumer insights and develop branding strategies; Marketing services; Marketing consulting; Marketing advisory services; Digital marketing services; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others; Consultancy regarding advertising communication strategies; Creative marketing plan development services; Creating and updating advertising material; Public relations; Public relations consultancy; Media relations services; Consulting in sales techniques and sales programs; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Consulting services in the field of medical product approval for commercial purposes; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of pharmaceutical development; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; Organizing business networking events in the field of pharmaceuticals; Organizing exhibitions for commercial or advertising purposesACTIVE—
041Arranging, conducting, and organization of seminars, lecture presentations and symposiums in the field of healthcare and pharmaceuticals for use by others in their internal training; Arranging and conducting of lectures in the field of healthcare and pharmaceuticals; Providing classes, seminars, workshops, presentations and retreats in the field of health; Consultancy relating to arranging and conducting of congresses; Consultancy relating to arranging and conducting of conferences; Arranging and conducting of conferences and symposia in the field of medical science; Business training; Arranging and conducting of training seminars in the field of pharmaceutical research; Writing of articles for professional journals other than for advertising or publicityACTIVE—
042Scientific research consulting; Technical consulting in the field of pharmaceutical studies; Research and development in the pharmaceutical and biotechnology fields; Consulting services in the field of pharmaceutical research and development; Providing medical research information in the field of pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trialsACTIVE—
045Providing information about legal eligibility requirements for government medical and pharmaceutical programs; Regulatory compliance consultancy in the field of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 29, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 23, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 3, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 2, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 2, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 2, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 4, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 4, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 4, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2026DOCKASSIGNED TO EXAMINER—
Feb 6, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 6, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 6, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance